美国NDC复合药物数据库文件

药品名称：商品名称：药品NDC：报告期内： -格式:2020-5-3
NDC包装id：市场分类：活性成分：持证企业：

美国NDC复合药物数据库文件1279条(本栏目收费,不能显示细节,电话13136136841)

药品名称(分析)

商品名

药品NDC

专利人(分析)

报告期内

活性成分

市场分类

规格(分析)

NDC包装id

TESTOSTERONE SA2 200MG

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

200 mg

70713-001-01

PROGESTERONE SA2 50MG

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

50 mg

70713-036-01

TESTOSTERONE ANASTROZOLE SA2 200MG 20MG

HUMAN COMPOUNDED DRUG

70713-014

Wells Pharmacy, Inc

2022/1/1 0:00:00

TESTOSTERONE; ANASTROZOLE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

200 mg; 20 mg

70713-014-01

TESTOSTERONE C 100MG

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

100 mg

70713-003-01

Sutter Formula

HUMAN COMPOUNDED DRUG

72196-0217

Central Admixture Pharmacy Services, Inc.

2021/2/1 0:00:00

LIDOCAINE HYDROCHLORIDE; SODIUM BICARBONATE; CALCIUM CHLORIDE; SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM ACETATE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE; DEXTROSE MONOHYDRATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

250 mg/572.64 mL; 1.26 g/572.64 mL; 6.8 meq/572.64 mL; 2.63 g/572.64 mL; 2.51 g/572.64 mL; 1.84 g/572.64 mL; 2.0475 g/572.64 mL; .15 g/572.64 mL; 10.57 g/572.64 mL

72196-0217-1

TESTOSTERONE C 12.5MG

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

12.5 mg

70713-040-01

TESTOSTERONE C 200MG

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

200 mg

70713-005-01

TESTOSTERONE C 25MG

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

25 mg

70713-032-01

TESTOSTERONE C 37.5MG

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

37.5 mg

70713-038-01

TESTOSTERONE C 50MG

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

50 mg

70713-023-01

Induction 4 to1 High K (30 meq) In PL A

HUMAN COMPOUNDED DRUG

72196-0212

Central Admixture Pharmacy Services, Inc.

2021/2/1 0:00:00

SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM ACETATE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE; SODIUM BICARBONATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

2.63 g/542 mL; 2.51 g/542 mL; 1.84 g/542 mL; 2.42 g/542 mL; .15 g/542 mL; 100 mg/542 mL; 1.848 g/542 mL

72196-0212-1

S-T303

HUMAN COMPOUNDED DRUG

79559-1303

F. H. Investments. Inc. DBA Asteria Health

2021/2/1 0:00:00

TESTOSTERONE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

303 mg/303 mg

79559-1303-1

Oxytocin

HUMAN COMPOUNDED DRUG

73702-121

Wells Pharma of Houston

2021/2/1 0:00:00

OXYTOCIN

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

20 mg/1000 mL

73702-121-06

Phenylephrine HCl

HUMAN COMPOUNDED DRUG

73702-122

Wells Pharma of Houston

2021/2/1 0:00:00

PHENYLEPHRINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

40 mg/250 mL

73702-122-03

Rocuronium

HUMAN COMPOUNDED DRUG

73702-129

Wells Pharma of Houston

2021/2/1 0:00:00

ROCURONIUM

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

10 mg/1 mL

73702-129-15

Phenylephrine HCl

HUMAN COMPOUNDED DRUG

73702-125

Wells Pharma of Houston

2021/2/1 0:00:00

PHENYLEPHRINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

100 ug/1 mL

73702-125-15

Phenylephrine HCl

HUMAN COMPOUNDED DRUG

73702-125

Wells Pharma of Houston

2021/2/1 0:00:00

PHENYLEPHRINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

100 ug/1 mL

73702-125-10

Fentanyl with 0.2% Ropivacaine

HUMAN COMPOUNDED DRUG

73702-211

Wells Pharma of Houston

2021/2/1 0:00:00

ROPIVACAINE HYDROCHLORIDE; FENTANYL

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

2 mg/1 mL; 2 ug/1 mL

73702-211-02

Oxytocin

HUMAN COMPOUNDED DRUG

73702-120

Wells Pharma of Houston

2021/2/1 0:00:00

OXYTOCIN

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

30 mg/500 mL

73702-120-05

Trophamine 3.5% / Dextrose 10% 250ml in 250ml bag

HUMAN COMPOUNDED DRUG

72196-0406

Central Admixture Pharmacy Services, Inc.

2021/2/1 0:00:00

LYSINE ACETATE; SERINE; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; GLUTAMIC ACID; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1.05 g/250 mL; .3325 g/250 mL; .0385 g/250 mL; .21 g/250 mL; .3675 g/250 mL; .021 g/250 mL; .42 g/250 mL; 1.05 g/250 mL; .021875 g/250 mL; 25 g/250 mL; 1.225 g/250 mL; .2975 g/250 mL; .4375 g/250 mL; .595 g/250 mL; .28 g/250 mL; .7175 g/250 mL; .4725 g/250 mL; .315 g/250 mL; .42 g/250 mL; .175 g/250 mL; .6825 g/250 mL

72196-0406-1

网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈

浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　

浙公网安备:330683240604819103159
　医药代理商群１：

医药代理商群２：

医药代理商群３：